Steps to understanding diabetes kidney disease: a focus on metabolomics

키워드

참고문헌 (56)

1. Alicic RZ, "Diabetic kidney disease : challenges, progress, and possibilities", Clin J Am Soc Nephrol, 12, pp.2032~2045 (2017)
2. Jin DC, "Analysis of mortality risk from Korean hemodialysis registry data 2017", Kidney Res Clin Pract, 38, pp.169~175 (2019)
3. Kim HJ, "Glomerular filtration rate as a kidney outcome of diabetic kidney disease : a focus on new antidiabetic drugs", Korean J Intern Med, 37, pp.502~519 (2022)
4. Kim DW, "Sarcopenia in chronic kidney disease : from bench to bedside", Korean J Intern Med, 38, pp.303~321 (2023)
5. Johansen KL, "US Renal Data System 2020 Annual Data Report: epidemiology of kidney disease in the United States", Am J Kidney Dis, 77(4 Suppl 1), pp.A7~A8 (2020)
6. Tong LL, "Diabetic kidney disease treatment : new perspectives", Kidney Res Clin Pract, 41(Suppl 2), pp.S63~S73 (2022)
7. Maruno S, "Exploring molecular targets in diabetic kidney disease", Kidney Res Clin Pract, 41(Suppl 2), pp.S33~S45 (2022)
8. Stevens PE, "Evaluation and management of chronic kidney disease : synopsis of the kidney disease : improving global outcomes 2012 clinical practice guideline", Ann Intern Med, 158, pp.825~830 (2013)
9. Fiorentino M, "Renal biopsy in patients with diabetes : a pooled meta-analysis of 48 studies", Nephrol Dial Transplant, 32, pp.97~110 (2017)
10. Gross JL, "Diabetic nephropathy : diagnosis, prevention, and treatment", Diabetes Care, 28, pp.164~176 (2005)
11. Jawa A, "Diabetic nephropathy and retinopathy", Med Clin North Am, 88, pp.1001~1036 (2004)
12. Umanath K, "Update on diabetic nephropathy : core curriculum 2018", Am J Kidney Dis, 71, pp.884~895 (2018)
13. Jiang G, "Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes", Kidney Int, 95, pp.178~187 (2019)
14. Newgard CB, "Metabolomics and metabolic diseases : where do we stand?", Cell Metab, 25, pp.43~56 (2017)
15. Jang C, "Metabolomics and isotope tracing", Cell, 173, pp.822~837 (2018)
16. Dumas ME, "Metabolome 2. 0 : quantitative genetics and network biology of metabolic phenotypes", Mol Biosyst, 8, pp.2494~2502 (2012)
17. Breit M, "Metabolic biomarkers for chronic kidney disease", Arch Biochem Biophys, 589, pp.62~80 (2016)
18. Dubin RF, "Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention", Clin J Am Soc Nephrol, 15, pp.404~411 (2020)
19. Davies R, "The metabolomic quest for a biomarker in chronic kidney disease", Clin Kidney J, 11, pp.694~703 (2018)
20. Lim JH, "Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection", Korean J Intern Med, 37, pp.520~533 (2022)
21. Jin Q, "Metabolomics in diabetes and diabetic complications : insights from epidemiological studies", Cells, 10, pp.2832~ (2021)
22. Sakashita M, "Metabolic changes and oxidative stress in diabetic kidney disease", Antioxidants(Basel), 10, pp.1143~ (2021)
23. Jung CY, "Novel biomarkers for diabetic kidney disease", Kidney Res Clin Pract, 41(Suppl 2), pp.S46~S62 (2022)
24. Hirayama A, "Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy", Anal Bioanal Chem, 404, pp.3101~3109 (2012)
25. Xia JF, "Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients", Clin Biochem, 42, pp.215~220 (2009)
26. Jiang Z, "HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols : application to studies of diabetic nephropathy", Talanta, 77, pp.1279~1284 (2009)
27. Han LD, "Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy", Anal Chim Acta, 689, pp.85~91 (2011)
28. Pena MJ, "Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus", Diabet Med, 31, pp.1138~1147 (2014)
29. Kim DW, "Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy : the DIAMOND study", Diabetes Res Clin Pract, 205, pp.110986~ (2023)
30. Darshi M, "Metabolomics in diabetic kidney disease : unraveling the biochemistry of a silent killer", Am J Nephrol, 44, pp.92~103 (2016)
31. Sharma K, "Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease", J Am Soc Nephrol, 24, pp.1901~1912 (2013)
32. Colombo M, "Serum kidney injury molecule 1 and β2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes", Diabetologia, 62, pp.156~168 (2019)
33. Kwan B, "Metabolomic markers of kidney function decline in patients with diabetes : evidence from the Chronic Renal Insufficiency Cohort(CRIC)study", Am J Kidney Dis, 76, pp.511~520 (2020)
34. Kwon S, "Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease : a targeted metabolomics study using nuclear magnetic resonance", Kidney Res Clin Pract, 42, pp.445~459 (2023)
35. Niewczas MA, "Uremic solutes and risk of end-stage renal disease in type 2 diabetes : metabolomic study", Kidney Int, 85, pp.1214~1224 (2014)
36. Kramer CK, "Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria", Diabetes Care, 30, pp.1998~2000 (2007)
37. MacIsaac RJ, "Nonalbuminuric renal insufficiency in type 2 diabetes", Diabetes Care, 27, pp.195~200 (2004)
38. Hirakawa Y, "Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics", Sci Rep, 12, pp.16287~ (2022)
39. Wang Z, "Glycine mitigates renal oxidative stress by suppressing Nox4 expression in rats with streptozotocin-induced diabetes", J Pharmacol Sci, 137, pp.387~394 (2018)
40. Yuan Y, "Clinical metabolomics characteristics of diabetic kidney disease : a meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls", Diabetes Metab Res Rev, 40, pp.e3789~ (2024)
41. Teo ZL, "Global prevalence of diabetic retinopathy and projection of burden through 2045 : systematic review and meta-analysis", Ophthalmology, 128, pp.1580~1591 (2021)
42. Jian Q, "Metabolomics in diabetic retinopathy : from potential biomarkers to molecular basis of oxidative stress", Cells, 11, pp.3005~ (2022)
43. Zhu XR, "Plasma metabolomic profiling of proliferative diabetic retinopathy", Nutr Metab(Lond), 16, pp.37~ (2019)
44. Chen L, "Plasma metabonomic profiling of diabetic retinopathy", Diabetes, 65, pp.1099~1108 (2016)
45. Yun JH, "Metabolomics profiles associated with diabetic retinopathy in type 2diabetes patients", PLoS One, 15, pp.e0241365~ (2020)
46. Tomofuji Y, "Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes", Commun Med(Lond), 3, pp.5~ (2023)
47. K P, "Predictive value of serum sialic Acid in type-2 diabetes mellitus and its complication(nephropathy)", J Clin Diagn Res, 7, pp.2435~2437 (2013)
48. El-Sayed MS, "Relationship between serum sialic acid concentration and diabetic retinopathy in Egyptian patients with type 2 diabetes mellitus", Benha Med J, 35, pp.257~263 (2018)
49. Li MN, "Correlation of serum N-Acetylneuraminic acid with the risk and prognosis of acute coronary syndrome : a prospective cohort study", BMC Cardiovasc Disord, 20, pp.404~ (2020)
50. Hu X, "New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era", Front Immunol, 15, pp.1342837~ (2024)
51. Sha Q, "Multi-omics analysis of diabetic nephropathy reveals potential new mechanisms and drug targets", Front Genet, 11, pp.616435~ (2020)
52. Wu IW, "Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease", NPJ Digit Med, 5, pp.166~ (2022)
53. Di Minno A, "Challenges in metabolomics-based tests, biomarkers revealed by metabolomic analysis, and the promise of the application of metabolomics in precision medicine", Int J Mol Sci, 23, pp.5213~ (2022)
54. Beale DJ, "Review of recent developments in GC-MS approaches to metabolomics-based research", Metabolomics, 14, pp.152~ (2018)
55. Tolstikov V, "Current status of metabolomic biomarker discovery : impact of study design and demographic characteristics", Metabolites, 10, pp.224~ (2020)
56. Bartroff J, "Sequential tests of multiple hypotheses controlling false discovery and nondiscovery rates", Seq Anal, 39, pp.65~91 (2020)

관련 논문AI추천